MedTrace Logo

Nitrates In Combination With Hydralazine in cardiorEnal Syndrome (NICHE) Study

NCT02343393 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2015-01-22

No results posted yet for this study

Summary

This is a single-blind, randomised, clinical trial assessing the efficacy of Hydralazine and Isosorbidedinitrate combination (oral agents) in HF patients with renal dysfunction.

Conditions

  • Cardio-Renal Syndrome

Interventions

DRUG

Hydralazine

DRUG

Isosorbide Dinitrate

Sponsors & Collaborators

  • Singapore Clinical Research Institute

    collaborator OTHER

  • Changi General Hospital

    collaborator OTHER

  • National Heart Centre Singapore

    collaborator OTHER

  • National University Hospital, Singapore

    lead OTHER

Principal Investigators

  • Su Ping Carolyn Lam, MBBS, MRCP, MS · National University Hospital, Singapore

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2015-12-31
Completion
2016-06-30

Countries

  • Singapore

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02343393 on ClinicalTrials.gov